26 July 2017

GSK Stockmann advises SCP Eisenzahnstraße on structuring and placement of a EUR 10 million real estate bond via iFunded

GSK Stockmann and Schiedermair Rechtsanwälte advised SCP Eisenzahnstraße 11-16 GmbH & Co. KG comprehensively on the structuring and the placement of their first collateralised bond. The public offer about EUR 10 million, made by the emitter SCP Eisenzahnstraße, came about through the online real estate investment platform iFunded.

For the financing of an existing property, the Berlin-based single-purpose company SCP Eisenzahnstraße 11-16 GmbH & Co. KG issued a fixed-interest collateralised bond of EUR 10 million. The bond is transmitted digitally via the online financing platform www.iFunded.de which is operated by iEstate GmbH, Berlin. SCHIEDERMAIR advised the online real estate investment platform iFunded on the expansion of its range of investment opportunities on securities issues. 

The bond instrument is increasingly used by real estate companies in order to secure liquidity for real estate projects and transactions in addition to the classic credit financing. These bonds are distributed via online platforms. This secured bond of EUR 10 million means that iFunded is entering a new dimension for digital financing platforms.

Advisors SCP Eisenzahnstraße:
GSK Stockmann: Dr. Timo Bernau, Andreas Heinzmann und Valerio Scollo (both GSK Luxemburg SA), Philippe Lorenz (all Banking / Capital market)

Schiedermair Rechtsanwälte: Dr. Matthias Möller (Corporate / Capital market); Associate: Lars Radziwon (Corporate / Capital market)

Advisors iFunded: 
Schiedermair Rechtsanwälte: Dr. Tobias Riethmüller (Corporate / Banking); 
Associate: Kathrin Bickert (Corporate / Banking)


Press contact
Beate Dünschede
+352 271802-29


GSK Updates
  • 06.02.2023

    GSK Update: Corporate News: Mobility Directive soon to be transposed in Germany and Luxembourg

    Read more
  • 27.01.2023

    GSK Update: ATAD III Directive Proposal legislative process: Vote of the EU Parliament Report

    Read more
  • 17.08.2022

    GSK Update: CAA Circular 22/15: What is new for the governance of insurance and reinsurance companies

    Read more
Contact person

Andreas Heinzmann, LL.M.


+352 271802-30


Valerio Scollo, LL.M.

Local Partner

+352 271802-32


© GSK Stockmann 2023